aripiprazole has been researched along with Acathisia, Drug-Induced in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 26 (44.83) | 29.6817 |
| 2010's | 31 (53.45) | 24.3611 |
| 2020's | 1 (1.72) | 2.80 |
| Authors | Studies |
|---|---|
| Garel, N; Joober, R | 1 |
| Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Sakuma, K | 1 |
| Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R | 1 |
| Cameron, C; Desai, D; Drake, C; Hutton, B; Kotb, A; Weiden, PJ; Zummo, J | 1 |
| Kamijima, K; Kimura, M; Kitayama, Y; Kuwahara, K; Tadori, Y | 1 |
| Blumberger, DM; Hsu, JH; Karp, JF; Lenze, EJ; Mulsant, BH; Reynolds, CF; Sanches, M | 1 |
| Fryefield, K; Shad, MU | 1 |
| Sakamoto, S; Sato, K; So, R; Tsukahara, M; Yoshimura, B; Yoshimura, Y | 1 |
| Chen, MH; Liou, YJ | 1 |
| De Berardis, D; Di Giannantonio, M; Martinotti, G; Moschetta, FS; Serroni, N | 1 |
| Higuchi, T; Ishigooka, J; Kamijima, K; Kanba, S; Kinoshita, T; Koyama, T; Ohmori, T; Ozaki, N | 1 |
| Bleickardt, CJ; Hodgson, RA; Hunter, JC; Jones, NT; Kazdoba, TM | 1 |
| Bergman, J; Pashinian, A; Poyurovsky, M; Weizman, A | 1 |
| Philip, NS | 1 |
| Fabbri, C; Kato, M; Kinoshita, T; Koshikawa, Y; Nonen, S; Okugawa, G; Sakai, S; Serretti, A; Sunada, N; Takekita, Y; Wakeno, M | 1 |
| Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
| Anderson, SJ; Begley, AE; Blumberger, DM; Butters, MA; Dew, MA; Karp, JF; Lenze, EJ; Mulsant, BH; Newcomer, JW; Reynolds, CF; Stack, JA | 1 |
| Caballero, J; Harrington, CA; Thomas, JE | 1 |
| Baglivo, V; Balestrieri, M; Brambilla, P; Gregoraci, G; Isola, M; Meduri, M | 1 |
| Baker, RA; Citrome, L; Nagamizu, K; Ota, A; Perry, P; Weiller, E | 1 |
| Chouinard, S; Huot, P; Selfani, K; Soland, VL | 1 |
| Endo, T; Miyake, N; Miyamoto, S; Ogino, S; Yamaguchi, N | 1 |
| Berman, RM; Carlson, BX; Fava, M; Marcus, RN; Nelson, CJ; Pikalov, A; Qi, Y; Thase, ME; Tran, QV; Trivedi, MH; Yang, H | 1 |
| Cho, DY; Lindenmayer, JP | 1 |
| Caykoylu, A; Ekinci, O; Yilmaz, E | 1 |
| Chen, CK; Ree, SC; Wang, LJ | 1 |
| Chen, CK; Wu, JH | 1 |
| Stip, E; Tourjman, V | 1 |
| Audino, B; Curtis, J; Donohue, AM; Filymer, DM; Finkel, N; Josiassen, RC; Kacso, M; Shaughnessy, RA; Skuban, N | 1 |
| Ebrecht, M; Kungel, M; Messer, T; Modell, S; Schmauss, M; Spevakne-Goeroecs, T; Werner, C | 1 |
| Friedman, JH | 1 |
| Berman, RM; Carlson, BX; Eudicone, JM; Khan, A; Pikalov, A; Tran, QV; Trivedi, MH; Weisler, RH; Yang, H | 1 |
| Albayrak, Y; Caykoylu, A; Ekinci, O; Ugurlu, GK | 1 |
| Babu, GN; Chandra, P; Kumar, R; Saddichha, S | 1 |
| Endo, T; Fukui, N; Ono, S; Shindo, M; Someya, T; Sugai, T; Suzuki, Y | 1 |
| Bowden, CL; Carlson, BX; Eudicone, JM; Marcus, R; McQuade, RD; Nashat, M; Thase, ME | 1 |
| Moteshafi, H; Stip, E | 1 |
| Higuchi, H; Sato, K; Yoshida, K | 1 |
| Connor, KM; Davidson, JR; Gadde, KM; Payne, VM; Zhang, W | 1 |
| Cohen, ST; Pies, R; Rulf, D | 1 |
| Scholten, MR; Selten, JP | 1 |
| Beers, E; Loonen, AJ; Van Grootheest, AC | 1 |
| Calabrese, JR; Carlson, BX; Carson, WH; Keck, PE; Marcus, RN; McQuade, RD; Rollin, LM; Sanchez, R | 1 |
| Malevani, J; Mobascher, A; Mobascher, J; Schlemper, V; Winterer, G | 1 |
| Balhara, YP; Kayal, M; Varghese, ST | 1 |
| Altshuler, LL; Frye, MA; Keck, PE; Leverich, GS; Martens, B; McElroy, SL; Post, RM; Stanford, K; Suppes, T | 1 |
| Dago, PL; Fleck, J; Gilmer, WS; Karaffa, M; Kemp, DE; Straus, JL | 1 |
| Dobkin, RD; Marin, H; Menza, MA | 1 |
| Chen, YY; Hung, GC | 1 |
| Lafollette, J; Lea, JW; Stoner, SC | 1 |
| Chen, CH; Huang, MC; Lu, ML | 1 |
| Carlson, B; Eudicone, J; McQuade, R; Pikalov, A; Suppes, T | 1 |
| Hettema, JM; Ross, DE | 1 |
| Chriki, LS; Dunn, RT; Filkowski, MM; Ghaemi, SN; Stan, VA | 1 |
| Poyurovsky, M; Weizman, A; Weizman, R | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Kelly, DL; Shim, JC; You, YS | 1 |
8 review(s) available for aripiprazole and Acathisia, Drug-Induced
| Article | Year |
|---|---|
Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Network Meta-Analysis; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Weight Gain | 2020 |
Efficacy and safety of aripiprazole lauroxil once-monthly versus aripiprazole once-monthly long-acting injectable formulations in patients with acute symptoms of schizophrenia: an indirect comparison of two double-blind placebo-controlled studies.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bayes Theorem; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Network Meta-Analysis; Randomized Controlled Trials as Topic; Schizophrenia; Weight Gain | 2018 |
The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis.
Topics: Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Aripiprazole; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Incidence; Lurasidone Hydrochloride; Schizophrenia | 2015 |
A meta-analysis of efficacy and safety of aripiprazole in adult and pediatric bipolar disorder in randomized controlled trials and observational studies.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Child; Gastrointestinal Diseases; Humans; Hyperprolactinemia; Male; Middle Aged; Observational Studies as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; Weight Gain; Young Adult | 2016 |
Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Nausea; Piperazines; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Weight Gain; Young Adult | 2010 |
Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Topics: Adult; Age Factors; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Piperazines; Quetiapine Fumarate; Quinolones; Risk Factors; Schizophrenia; Sex Characteristics; Treatment Outcome; Young Adult | 2012 |
Aripiprazole in bipolar depression: a pooled, post-hoc analysis by severity of core depressive symptoms.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Depression; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult | 2012 |
Comparing tolerability profile of quetiapine, risperidone, aripiprazole and ziprasidone in schizophrenia and affective disorders: a meta-analysis.
Topics: Adult; Affective Disorders, Psychotic; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Humans; Hypercholesterolemia; Incidence; Pharmacovigilance; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Thiazoles | 2012 |
17 trial(s) available for aripiprazole and Acathisia, Drug-Induced
| Article | Year |
|---|---|
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult | 2017 |
Randomized, double-blind comparison of aripiprazole/sertraline combination and placebo/sertraline combination in patients with major depressive disorder.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasopharyngitis; Outcome Assessment, Health Care; Sertraline; Single-Blind Method; Young Adult | 2018 |
Clinical Predictors of Extrapyramidal Symptoms Associated With Aripiprazole Augmentation for the Treatment of Late-Life Depression in a Randomized Controlled Trial.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Female; Humans; Late Onset Disorders; Male; Parkinson Disease, Secondary; Risk Factors; Time Factors | 2018 |
Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: a randomized, double-blind, placebo-controlled study (ADMIRE study).
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Asian People; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome | 2013 |
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Drug Partial Agonism; Female; Humans; Isoindoles; Male; Middle Aged; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Young Adult | 2015 |
Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial.
Topics: Aged; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Recurrence; Treatment Outcome | 2015 |
The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Quinolones; Schizophrenia; Serotonin Agents; Thiophenes; Treatment Outcome; Weight Gain | 2016 |
Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Body Weight; Comorbidity; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Inventory; Piperazines; Quinolones; Treatment Outcome | 2008 |
Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Time Factors | 2010 |
Clinical use of aripiprazole in patients with schizophrenia: a real-life setting results from the German Postmarketing Surveillance Study.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Germany; Humans; Male; Nausea; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Sleep Initiation and Maintenance Disorders; Vomiting | 2010 |
Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.
Topics: Adult; Age Factors; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Depressive Disorder, Major; Double-Blind Method; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Quinolones; Suicidal Ideation; Time Factors; Young Adult | 2011 |
The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Drug Administration Schedule; Humans; Male; Nausea; Obesity; Obsessive-Compulsive Disorder; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome; Weight Gain | 2005 |
A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cross-Cultural Comparison; Double-Blind Method; Female; Humans; International Cooperation; Male; Pain; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Secondary Prevention; Time Factors; Treatment Outcome | 2006 |
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2007 |
Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Topics: Acute Disease; Adolescent; Adult; Age Distribution; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Quinolones; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2008 |
A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
Topics: Acute Disease; Adolescent; Adult; Akathisia, Drug-Induced; Ambulatory Care; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Female; Humans; Lorazepam; Male; Middle Aged; Nausea; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Treatment Outcome | 2008 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
33 other study(ies) available for aripiprazole and Acathisia, Drug-Induced
| Article | Year |
|---|---|
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Delusions; Dystonia; Female; Hallucinations; Humans; Hypnotics and Sedatives; Intellectual Disability; Lorazepam; Loxapine; Olanzapine; Paranoid Disorders; Psychotic Disorders; Quetiapine Fumarate; Tourette Syndrome | 2019 |
Can low-dose aripiprazole reverse some of the adverse effects from a long-acting injectable?
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Hyperprolactinemia; Injections; Psychotic Disorders | 2019 |
Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Predictive Value of Tests; Retrospective Studies; Risperidone; Schizophrenia; Severity of Illness Index; Treatment Outcome | 2019 |
Aripiprazole-associated acute dystonia, akathisia, and parkinsonism in a patient with bipolar I disorder.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dystonia; Female; Humans; Parkinsonian Disorders; Piperazines; Quinolones | 2013 |
Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin.
Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; gamma-Aminobutyric Acid; Humans; Piperazines; Pregabalin; Quinolones | 2013 |
Antagonism of the adenosine A2A receptor attenuates akathisia-like behavior induced with MP-10 or aripiprazole in a novel non-human primate model.
Topics: Adenosine A2 Receptor Antagonists; Akathisia, Drug-Induced; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Cebus; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Motor Activity; Phosphodiesterase Inhibitors; Piperazines; Pyrazoles; Pyrimidines; Quinolines; Quinolones; Triazoles | 2014 |
Beneficial effect of low-dose mirtazapine in acute aripiprazole-induced akathisia.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Diagnostic and Statistical Manual of Mental Disorders; Dopamine D2 Receptor Antagonists; Female; Histamine H1 Antagonists; Hospitals, Psychiatric; Humans; Israel; Male; Mianserin; Middle Aged; Mirtazapine; Off-Label Use; Piperazines; Quinolones; Retrospective Studies; Severity of Illness Index; Young Adult | 2014 |
An aripiprazole discontinuation syndrome.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fluoxetine; Humans; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2013 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Tardive Dyskinesia; Young Adult | 2017 |
Successful treatment of delusional disorder with low-dose aripiprazole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia, Paranoid; Treatment Outcome | 2008 |
Aripiprazole-induced agitation after clozapine discontinuation: a case report.
Topics: Akathisia, Drug-Induced; Alcoholism; Antipsychotic Agents; Aripiprazole; Clozapine; Cocaine-Related Disorders; Comorbidity; Delayed-Action Preparations; Diabetic Ketoacidosis; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Middle Aged; Molindone; Piperazines; Quinolones; Schizophrenia, Paranoid; Substance Withdrawal Syndrome | 2009 |
Resolution of risperidone-induced tardive dyskinesia with a switch to aripiprazole monotherapy.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Piperazines; Quinolones; Risperidone; Schizophrenia | 2009 |
Courses of aripiprazole-associated tardive dyskinesia: report of two cases.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Middle Aged; Piperazines; Quinolones | 2009 |
Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Quinolones; Risperidone | 2009 |
Warning on treating depression.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Depression; Dopamine Antagonists; Gastrointestinal Diseases; Humans; Metoclopramide; Piperazines; Quinolones | 2010 |
Aripiprazole-associated bruxism, akathisia, and parkinsonism in a bipolar patient.
Topics: Akathisia, Drug-Induced; Aripiprazole; Bipolar Disorder; Bruxism; Female; Humans; Parkinson Disease, Secondary; Piperazines; Quinolones; Young Adult | 2011 |
Aripiprazole associated with acute dystonia, akathisia, and parkinsonism in a single patient.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Depression; Dystonia; Female; Fluoxetine; Humans; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones | 2012 |
Probable aripiprazole-induced tardive writer's cramp.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dystonic Disorders; Humans; Male; Piperazines; Quinolones; Schizophrenia, Paranoid; Young Adult | 2012 |
Extrapyramidal side effects associated with aripiprazole coprescription in 2 patients.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
[Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Suicide, Attempted; Thinking | 2005 |
[Suicidal ideations and suicide attempts after starting on aripiprazole, a new antipsychotic drug].
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Piperazines; Psychotic Disorders; Quinolones; Sleep Wake Disorders; Suicide, Attempted | 2006 |
Aripiprazole pharmacotherapy of borderline personality disorder.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Cognitive Behavioral Therapy; Combined Modality Therapy; Comorbidity; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Personality Assessment; Piperazines; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones | 2006 |
Neuroacanthocytosis: presenting with depression.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dystonia; Female; Humans; Piperazines; Psychotic Disorders; Quinolones | 2006 |
Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Patient Dropouts; Pilot Projects; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones | 2007 |
Aripiprazole augmentation in treatment-resistant bipolar depression: early response and development of akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Synergism; Female; Humans; Male; Middle Aged; Piperazines; Quinolones | 2007 |
Extrapyramidal side effects associated with aripiprazole administration in a schizophrenic patient.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Male; Parkinsonian Disorders; Piperazines; Quinolones; Schizophrenia | 2007 |
Agitation associated with aripiprazole initiation.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Quinolones; Receptors, Dopamine; Schizophrenia, Paranoid; Up-Regulation | 2007 |
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Appetite; Aripiprazole; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Metabolic Diseases; Obesity; Olanzapine; Piperazines; Quinolones; Schizophrenia; Weight Gain | 2007 |
A case of aripiprazole-related tardive akathisia and its treatment with ropinirole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Female; Humans; Indoles; Middle Aged; Piperazines; Quinolones; Schizophrenia | 2007 |
Aripiprazole's receptor pharmacology and extrapyramidal side effects.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Humans; Piperazines; Piperidines; Positron-Emission Tomography; Psychomotor Agitation; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Urea | 2008 |
Aripiprazole improves neuroleptic-associated tardive dyskinesia, but it does not meliorate psychotic symptoms.
Topics: Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Male; Piperazines; Quinolones | 2008 |
Aripiprazole treatment causes extrapyramidal side effects but not prolactin elevation: a disconnect of the striatal D2 occupancy story: case report.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benztropine; Corpus Striatum; Dose-Response Relationship, Drug; Humans; Male; Piperazines; Prolactin; Quinolones; Receptors, Dopamine D2; Schizophrenia | 2008 |